Physical Scientists May Be Key To Speedup of Gene Sequencing

Chemist Lloyd M. Smith's entry into the world of gene sequencing came about during his postdoc days, in Leroy Hood's molecular biology lab at the California Institute of Technology in Pasadena. With his background in fluorescence chemistry and instrumentation, Smith saw a way to speed the tedious process of reading DNA sequences off gels. The result was the development of the first automated DNA sequencer (L.M. Smith, et al., "Fluorescence Detection in Automated DNA Sequence Analysis," Nature,

Written byChristine Mlot
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

For Smith and other physical scientists, the grail of the government's Human Genome Project (HGP) is not the sequence and analysis of our 3 billion DNA bases, as it is for the biologists, but the technology that will actually do it. Armed with an array of analytical hardware such as mass spectrometers, scanning tunneling microscopes, and flow cytometers, these physicists and chemists are seeking new and improved systems that can read the order of the four nucleotide bases from the stretch of DNA.

While many of the ideas for new sequencing technologies have been around since the mid-1980s, the HGP in the last two years has spurred the pace of their development. It has also created a niche for collaborations among physical scientists and molecular biologists, says Jane Peterson, chief of research centers for the National Institutes of Health's HGP effort. Developing new sequencing technologies "takes interdisciplinary work," she says. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies